WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

STUDY OF PHARMACOLOGICAL MANAGEMENT OF PATIENTS SUFFERING FROM DILATED CARDIOMYOPATHY

Sanjeev Dhakal*, Sabyata Gautam Dr. Sujeeb Rajbhandari Sujyoti Shakya, Rajendra Ayer

ABSTRACT

Dilated Cardiomyopathy represents a significant health problem as it can lead to progressive refractory heart failure and represents the majority of indications for heart transplantations. In dilated cardiomyopathy, the heart is enlarged, all the chambers are severely dilated and the heart muscle is pale and flabby. A descriptive crosssectional hospital based study was carried out in the patients admitted with dilated cardiomyopathy at Shahid Gangalal National Heart Centre. The study was carried out for three months from July to October 2014. Structured questionnaire was used as a tool for the collection of information through interview with the patient or caretaker during the hospital stay. The primary data collection included demographic pattern, risk factors, symptoms, diagnostic criteria, blood tests, medication pattern. Among the 100 patients, there were 51 male and 49 female. In the study group, 40% of the patients were smokers and 30% of the patients were drinkers, 43% of the patients were associated with either of the disease hypertension, diabetes mellitus and chronic obstructive pulmonary disease. Among 49 women, 5 women were associated with peripartum and postpartum dilated cardiomyopathy. All patients were presented with dilation of left ventricle. All patients were treated with loop diuretics and were also treated with Aldosterone antagonist, ACE inhibitors, Beta blockers, inotropic agents, Antiplatelet and statins. The average cost of the treatment of the patients with dilated cardiomyopathy was found to be expensive. The patients were managed pharmacologically to prevent the deterioration of the disease and to treat the underlying symptoms.

Keywords: Dilated Cardiomyopathy, Idiopathic, Peripartum, Mitral, Dilation.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More